News of the index components SMI

Index

SMI

CH0009980894

Market Closed - Swiss Exchange 11:30:33 2024-07-15 EDT			5-day change	1st Jan Change
12,280 ^PTS	-0.69%		+1.89%	+10.25%

07-15	Swiss Market Index Closes Lower; Swatch Group Slumps	MT
07-15	Swiss Monthly Producer, Import Prices Unchanged in June	MT

News of the index components

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Alcon : Completes Acquisition of BELKIN Vision, Expanding Glaucoma Portfolio with Direct Selective Laser Trabeculoplasty (DSLT) Device ALC	07-01	PU
Alcon : Completes Acquisition of BELKIN Vision, Expanding Glaucoma Portfolio with Direct Selective Laser Trabeculoplasty (DSLT) Device ALC	07-01	PU
ROCHE HOLDINGS AG : Deutsche Bank remains Neutral ROG	07-01	ZD
GIVAUDAN AG : Goldman Sachs maintains a Buy rating GIVN	07-01	ZD
Lonza Group's New CEO Assumes Role LONN	07-01	MT
BioPharma Credit to Provide Additional Funding to LumiraDx Amid Roche Deal ROG	07-01	MT
Partners Group to Buy Majority Stake in FairJourney Biologics PGHN	07-01	MT
Partners Group to Buy Majority Stake in Biotech FairJourney Biologics PGHN	07-01	DJ
Partners Group to acquire majority stake in FairJourney Biologics, a leading antibody discovery Contract Research Organization PGHN	07-01	EQ
Lonza Welcomes New Group Chief Executive Officer Wolfgang Wienand LONN	07-01	EQ
Partners Group Signs Deal for Majority Stake in FairJourney Biologics PGHN	07-01	MT
Nestlé Expects Growth from Volume, Product Mix for Remainder of FY24 NESN	07-01	MT
Givaudan SA acquired remaining 75% stake in B. Kolormakeup & Skincare S.p.a. GIVN	06-30	CI
Nestle sees stable sales growth from Q2, CEO tells paper NESN	06-29	RE
BNP Paribas Exane Lowers Price Target on Swatch Group, Maintains Neutral Recommendation GIVN	06-28	MT
Roche's Eye Therapy Vabysmo Gets EU Panel's Nod for Additional Indication ROG	06-28	MT
Roche: positive CHMP opinion for Vabysmo in OVR ROG	06-28	CF
Roche: positive CHMP opinion for PiaSky in HPN ROG	06-28	CF
Roche Gets EU Panel's Backing for Rare Blood Disorder Therapy ROG	06-28	MT
Roche's Vabysmo Wins EMA Panel's Backing for Retinal Vein Occlusion Indication ROG	06-28	MT
Roche's Vabysmo Gets CHMP Recommendation for Third Indication Retinal Vein Occlusion ROG	06-28	CI
Roche's Rare Blood Disorder Drug PiaSky Backed for Approval in EU ROG	06-28	MT
Chmp Recommends EU Approval of Roche?S Piasky for People with Pnh, A Rare, Life-Threatening Blood Condition ROG	06-28	CI
Holcim: plans to deploy AI in more plants LHN	06-27	CF
Partners Group’s announcement of AuM as of 30 June 2024 PGHN	06-27	EQ
Holcim to Expand AI Use Across Manufacturing Sites to Bolster Capacity LHN	06-27	MT
Kuehne+Nagel Launches New Cross-dock Warehouses in US KNIN	06-27	MT
Roche: WHO prequalification for HPV testing ROG	06-27	CF
Roche Receives Additional Prequalification Designations for HPV Test ROG	06-27	MT
Holcim to deploy Artificial Intelligence to reinforce manufacturing capacity for customers LHN	06-27	EQ
Sadif Investment Analytics Lowers Price Target on Nestle, Upgrades Recommendation to Strong Buy From Buy NESN	06-26	MT
Holcim : invests in Travertine to advance decarbonized cement and circularity LHN	06-26	PU
Nestlé: platform to surf on anti-obesity pills NESN	06-25	CF
Nestle launches website for individuals on weight loss drugs NESN	06-25	RE
Nestle S A : Nestlé Human Rights Policy NESN	06-25	PU
Roche: approval of Ocrevus SC in Europe ROG	06-25	CF
Roche Wins EU Nod for Subcutaneous Formula of Multiple Sclerosis Drug Ocrevus ROG	06-25	MT
Roche's Multiple Sclerosis Injection Gets EU Approval ROG	06-25	DJ
Roche Announces the European Commission Grants Marketing Authorisation for OCREVUS (Ocrelizumab) Subcutaneous for the Treatment of Relapsing Multiple Sclerosis and Primary Progressive Multiple Sclerosis ROG	06-25	CI
Ecom Express Private Limited announced that it expects to receive INR 14.24147 billion in funding from Warburg Pincus LLC, British International Investment plc, Partners Group Holding AG PGHN	06-24	CI